@Domesticgod It wasn’t the former CEO, but rather the Chairman who told shareholders at the AGM that he would not let directors purchase shares (over the last 9 months or so). You probably got distracted by the Chairman making repeated, flippant and totally unnecessary jokes about director’s AFL club memberships. All this joviality whilst shareholders sit there having taken it in the neck and had their investment in SPL absolutely tank.What an absolute slap in the face this was for long suffering shareholders.
And @col69 I just cannot fathom that the newly appointed CEO could possibly remain a director of a Sydney based ASX-listed company. A Clarity resignation notice surely will be forthcoming before the end of this month. If not, this will be the mother of all red flags indicating just more of the same ahead for shareholders and Starpharma as the company inches one day closer to inevitable removal from the All Ordinaries Index in March 2024.
What an achievement this will be. Slow golf clap for all concerned.
SPL Price at posting:
16.0¢ Sentiment: Sell Disclosure: Not Held
